Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis

OBJECTIVES: Previously we demonstrated the benefit of isavuconazole in treating murine mucormycosis due to Rhizopus. We wanted to determine the efficacy of isavuconazole in treating murine mucormycosis caused by Mucor, the second most common cause of the disease. Furthermore, because we previously d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Antimicrob Chemother
Hauptverfasser: Gebremariam, Teclegiorgis, Wiederhold, Nathan P., Alqarihi, Abdullah, Uppuluri, Priya, Azie, Nkechi, Edwards, John E., Ibrahim, Ashraf S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2017
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6289498/
https://ncbi.nlm.nih.gov/pubmed/27798213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw433
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge